InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
2.240
+0.010 (0.45%)
At close: Jul 3, 2025, 1:00 PM
2.250
+0.010 (0.45%)
After-hours: Jul 3, 2025, 4:18 PM EDT
InspireMD Employees
As of December 31, 2024, InspireMD had 86 total employees, including 85 full-time and 1 part-time employees. The number of employees increased by 20 or 30.30% compared to the previous year.
Employees
86
Change (1Y)
20
Growth (1Y)
30.30%
Revenue / Employee
$81,709
Profits / Employee
-$420,221
Market Cap
68.62M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NSPR News
- 10 days ago - InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke - GlobeNewsWire
- 21 days ago - InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke - GlobeNewsWire
- 4 weeks ago - InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer - GlobeNewsWire
- 2 months ago - InspireMD, Inc. (NSPR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - InspireMD Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference - GlobeNewsWire
- 2 months ago - InspireMD to Announce First Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire